Fabian Kreutzer finished his PhD in Molecular Medicine at Hannover Biomedical Research School (HBRS) and has a background in biotechnology. He is working in the Institute of Molecular and Translational Therapeutic Strategies (IMTTS), where he analyses novel natural compounds and their potential in the treatment of heart failure.
HFWM: Natural compound-derived small molecules to target fibrosis
Event: Heart Failure 2019
Topic: Cardiac Diseases
Session: Basic science - Cardiomyopathies
ESC 365 is supported by
